Actions
Incoming Resources
- Ryan White Care Act, AIDS drug assistance programs, perinatal HIV transmission, and partner notification : testimony before the Subcommittee on Federal Financial Management, Government Information, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate, statement of Marcia Crosse
- Drug shortages, threat to public health persists, despite actions to help maintain product availability, testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Defense health care, status of fiscal year 2004 requirements for reservists' benefits and monitoring beneficiaries' access to care
- Defense health care, DOD has established a chiropractic benefit for active duty personnel
- Influenza pandemic, challenges remain in preparedness : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Defense health care, occupational and environmental health surveillance conducted during deployments needs improvement : testimony before the Subcommittee on National Security, Emerging Threats, and International Relations, Committee on Government Reform, House of Representatives, statement of Marcia Crosse
- Drug safety, FDA needs to further address shortcomings in its postmarket decision-making process : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Military health, DOD's vaccine healthcare centers network
- Drug safety, preliminary findings suggest weaknesses in FDA's program for inspecting foreign drug manufacturers : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Prescription drugs, FDA guidance and regulations related to data on elderly persons in clinical drug trials
- Food and Drug Administration, employee performance standards for the timely review of medical product applications, [Marcia Crosse]
- Ryan White CARE Act, estimated effect of proposed stop-loss provision on urban areas, [Marcia Crosse]
- Drug shortages, FDA's ability to respond should be strengthened : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate, statement of Marcia Crosse
- Influenza pandemic, applying lessons learned from the 2004-05 influenza vaccine shortage : testimony before the Committee on Government Reform, House of Representatives, statement for the Record by Marcia Crosse
- National preparedness, countermeasures for thermal burns, [Marcia Crosse]
- Abstinence education, assessing the accuracy and effectiveness of federally funded programs : testimony before the Committee on Oversight and Government Reform, House of Representatives, statement of Marcia Crosse
- Veterans' health care, oversight of tissue product safety, testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives, statement of Marcia Crosse
- Drug safety, further actions needed to improve FDA's postmarket decision-making process : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Ryan White Care Act, factors that impact HIV and AIDS funding and client coverage : testimony before the Subcommittee on Federal Financial Management, Government Information, and International Security, Committee on Homeland Security and Governmental Affairs, U.S. Senate, statement of Marcia Crosse
- Ryan White CARE Act, estimated effect of continued application of the fiscal year 2010 stop-loss provision on 2011 funding for urban areas, [Marcia Crosse]
- Ryan White Care Act, changes needed to improve the distribution of funding : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Prescription drugs, state monitoring programs may help to reduce illegal diversion, statement of Marcia Crosse, Director, Health Care, Public Health and Military Health Care Issues
- Medical devices, FDA faces challenges in conducting inspections of foreign manufacturing establishments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Drug safety, preliminary findings suggest recent FDA initiatives have potential, but do not fully address weaknesses in its foreign drug inspection program : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Ryan White Care Act, program changes affecting minority AIDS initiative and Part D grantees : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Influenza, progress made in responding to seasonal and pandemic outbreaks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Internet pharmacies, most rogue sites operate from abroad, and many sell counterfeit drugs, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Medical devices, challenges for FDA in conducting manufacturer inspections : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Federal funds, fiscal years 2002-2009 obligations, disbursements, and expenditures for selected organizations involved in health-related activities, [Marcia Crosse]
- Prescription drugs, trends in FDA's oversight of direct-to-consumer advertising : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Military personnel, medical, family support, and educational services are available for exceptional family members
- Influenza pandemic, challenges in preparedness and response : testimony before the Committee on Government Reform, House of Representatives, statement of Marcia Crosse
- Medical devices, shortcomings in FDA's premarket review, postmarket surveillance, and inspections of device manufacturing establishments : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Ryan White CARE Act, estimated effect of proposed stop-loss provision in H.R. 3293 on urban areas, [Marcia Crosse]
- Dietary supplements containing ephedra, health risks and FDA's oversight : statement of Marcia Crosse, Acting Director, Health Care--Public Health and Science Issues, before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, United States General Accounting Office
- Tobacco products, FDA spending and new product review time frames, testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Internet pharmacies, some pose safety risks for consumers and are unreliable in their business practices : testimony before the Permanent Subcommittee on Investigations, Committee on Governmental Affairs, U.S. Senate, statement of Marcia Crosse
- Temporomandibular joint and muscle disorders, NIH supports a wide range of research
- Global malaria control, U.S. and multinational investments and implementation challenges
- Pediatric drug research, the study and labeling of drugs for pediatric use under the Best Pharmaceuticals for Children Act : testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Ryan White Care Act, impact of legislative funding proposal on urban areas
- Ryan White CARE Act, estimated effect of draft stop-loss provision, [Marcia Crosse]
- Defense health care, issues related to past drinking water contamination at Marine Corps Camp Lejeune : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Drug safety, FDA faces challenges overseeing the foreign drug manufacturing supply chain : testimony before the Committee on Health, Education, Labor, and Pensions, U.S. Senate, statement of Marcia Crosse
- Drug shortages, threat to public health persists, despite actions to help maintain product availability, testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Veterans' health care, oversight of tissue product safety, testimony before the Subcommittee on Oversight and Investigations, Committee on Veterans' Affairs, House of Representatives, statement of Marcia Crosse
- Federal autism activities, funding and coordination efforts, testimony before the Subcommittee on Government Operations, Committee on Oversight and Government Reform, House of Representatives, statement of Marcia Crosse
- Influenza, progress made in responding to seasonal and pandemic outbreaks : testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Internet pharmacies, most rogue sites operate from abroad, and many sell counterfeit drugs, testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse
- Tobacco products, FDA spending and new product review time frames, testimony before the Subcommittee on Health, Committee on Energy and Commerce, House of Representatives, statement of Marcia Crosse